Table 2.
Baseline values for patients in the bariatric surgery therapy group and the conventional medication therapy group.
| Unmatched cohort | Propensity score-matched cohort | |||||
|---|---|---|---|---|---|---|
| Demographic information | Bariatric surgery therapy group | Conventional medication therapy group | P value | Bariatric surgery therapy group | Conventional medication therapy group | P value |
| Demographic | ||||||
| Sample size (patients) | 134 | 81 | 41 | 41 | ||
| Sex (female) | 65 | 27 | 0.029† | 24 | 22 | 0.66† |
| Age (years)a | 39.05 ± 12.03 | 42.54 ± 12.04 | 0.040‡ | 41.54 ± 11.85 | 42.90 ± 11.18 | 0.60‡ |
| BMI (kg/m2)a | 36.47 ± 8.15 | 33.65 ± 4.12 | 0.001‡ | 32.73 ± 4.52 | 34.34 ± 3.26 | 0.07‡ |
| Clinical data | ||||||
| Fasting plasma glucosea | 9.74 ± 2.98 | 8.91 ± 2.31 | 0.021‡ | 8.90 ± 2.43 | 8.54 ± 2.47 | 0.52‡ |
| Glycated haemoglobina | 8.49 ± 1.46 | 7.93 ± 1.84 | 0.033‡ | 9.12 ± 1.55 | 9.67 ± 1.70 | 0.13‡ |
| Diabetes status (after 2 years) | ||||||
| No. with T2DM remission (patients) | 71 | 4 | <0.0001† | 22 | 1 | <0.0001† |
| No. with T2DM (patients) | 63 | 77 | 19 | 40 | ||
| No. of death (patients) | 0 | 0 | 0 | 0 | ||
aValues are presented as the mean ± standard deviations. †χ2 test; ‡t-test.